Related content

Assessing and Treating Cognitive Impairment in Schizophrenia: Current and Future

By  

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5127-5138

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Targeting the Ionotropic Glutamate Receptors in Treating Schizophrenia

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1535-1542

Bentham Science Publishers

Access to resources Recommend Favorite

Preattentional and attentional cognitive deficits as targets for treating schizophrenia

By Braff David   Light Gregory  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 75-85

Springer Publishing Company

Access to resources Recommend Favorite

Intracellular Signaling and Approaches to the Treatment of Schizophrenia and Associated Cognitive Impairment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 5093-5103

Bentham Science Publishers

Access to resources Recommend Favorite

The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 5104-5114

Bentham Science Publishers

Access to resources Recommend Favorite